If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksprobiotix health Regulatory News (PBX.PL)

Share Price Information for probiotix health (PBX.PL)

Share Price is delayed by 15 minutes
Get Live Data
7.75    0.00 (0.00%)
Bid:
7.50
Ask:
8.00
Spread: 0.50 (6.667%)
Market Cap: £12.26m
PBX.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday probiotix health Share Chart

Total Voting Rights

30 Sep 2024 14:03

RNS Number : 2865G
Probiotix Health PLC
30 September 2024
 

30 September 2024

ProBiotix Health plc

("ProBiotix" or the "Company" or, together with its subsidiary, the "Group")

 

Total Voting Rights

 

ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, announces that the Company has 158,166,666 ordinary shares of 0.05p each in issue ("Ordinary Shares"), each share carrying the right to one vote.

 

This figure of 158,166,666 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

For further information, please contact:

 

ProBiotix Health plc

https://probiotixhealth-ir.com/

Steen Andersen, Chief Executive Officer

 

Peterhouse Capital Limited

Aquis Corporate Adviser And Broker

Tel: 020 7220 9793

Mark Anwyl

 

Walbrook PR Ltd

Anna Dunphy

 

probiotix@walbrookpr.com

Mob: 07876 741 001

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXEAANEDSXLEFA
12
Date   Source Headline
15th Aug 20247:00 amRNSNew commercial partnership agreement in China
8th Aug 20242:14 pmRNSResult of AGM
15th Jul 20247:00 amRNSSix month trading update
28th Jun 20247:00 amRNSFinal Results
26th Feb 20247:00 amRNSPartner agreement with SymbioPharm
9th Feb 20247:00 amRNSChange of auditor
31st Jan 20247:00 amRNSNew appointment
11th Jan 20247:00 amRNSDirectorate Change
27th Sep 20237:00 amRNSHalf-year Report
1st Aug 20237:00 amRNSDistribution agreement
26th Jul 202312:34 pmRNSResult of AGM
24th Jul 20237:00 amRNSNew appointment
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.